ArticleFrontiers in medicine2025

Case Report: Effective use of eculizumab in treating recurrent atypical HUS following renal transplantation triggered by SARS-CoV-2 infection.

Zhe Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.